跳至主要内容
临床试验/ITMCTR2200005559
ITMCTR2200005559招募中未知

Study on Clinical, pathological and TCM Syndromes of IgA Nephropathy with malignant Hypertension

Chinese PLA General Hosptial0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • Inclusion criteria (1) this study was approved by the ethics committee of the first medical center of the PLA General Hospital (ethics approval No.: s2021-165-01). The retrospective patients were exempted from signing informed consent, and the prospective patients voluntarily participated in this study and signed informed consent. (2) After 2013, patients with primary IgA nephropathy diagnosed by renal biopsy in the Department of Nephrology of the first medical center of the PLA General Hospital. (3) In hospital diagnosis of renal puncture with malignant hypertension [10], that is, the blood pressure is significantly elevated, usually > 200 / 120mmhg, and can be accompanied by significant bilateral retinopathy (flame hemorrhage, cotton wool spots or optic papilledema). (4) The age of renal biopsy was over 18 years old (including 18 years old), regardless of gender; (5) There was a questionnaire of traditional Chinese medicine within 7 days before and after renal biopsy.

排除标准

  • (1) the number of evaluable glomeruli was less than 8; (2) Secondary IgA nephropathy such as purpura nephritis, lupus nephritis and hepatitis B; (3) Other renal diseases such as membranous nephropathy; (4) combined with diabetes, connective tissue disease and other systemic diseases. (5) The medical records are incomplete.

研究者

发起方
Chinese PLA General Hosptial

相似试验